
|Articles|April 1, 2004
Verification of a Decision Analytic Model Assumption Using Real-world Practice Data: Implications for the Cost Effectiveness of Cyclo-oxygenase 2 Inhibitors (COX-2s)
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
3
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
4
How Clinician-Led Partnerships Strengthen Post-Acute Care
5